2016 Department of Pathology & Laboratory Medicine Annual Report
Total Page：16
File Type：pdf, Size：1020Kb
Executive Summary 3 Executive Summary _____________________________________________________________________ 3 Departmental Structure and Organization 4 Governance __________________________________________________________________________ 4 Departmental Committees ________________________________________________________________ 6 Divisions, Sections and/or Programs ________________________________________________________ 7 Membership (Appendix 1.1) ______________________________________________________________ 7 Accomplishments and Highlights 8 Clinical Service (by Section) ______________________________________________________________ 8 Anatomical Pathology/Cytopathology Section (AP/Cyto) ________________________________________ 8 Clinical Biochemistry Section ______________________________________________________________ 9 General Pathology Section ______________________________________________________________ 12 Hematopathology Section _______________________________________________________________ 25 Microbiology Section __________________________________________________________________ 29 Transfusion Medicine Section ____________________________________________________________ 31 Education ___________________________________________________________________________ 33 Publications __________________________________________________________________________ 40 Research Grants ______________________________________________________________________ 42 Medical Leadership and Administration_____________________________________________________ 42 Challenges 42 Responses to Issues, Ongoing Matters and Plan of Action ______________________________________ 43 Future Risks __________________________________________________________________________ 43 Workforce Planning 43 Appendices 43 1.1 Membership Lists ___________________________________________________________________ 43 1.2 Current Workforce Plan (see Workforce Planning) __________________________________________ 46 1.3 Scholarly Publications _______________________________________________________________ 46 1.4 Research Grants ___________________________________________________________________ 59 1.5 Banff Pathology Course ______________________________________________________________64 1 Submitted by: Dr. Christopher Naugler Associate Professor and Head Department of Pathology & Laboratory Medicine University of Calgary, Cumming School of Medicine Alberta Health Services - Calgary Zone Acknowledgements: Thomas Kryton, BFA Graphic Design and Layout Photography Content Prepared by: Christopher Naugler Sherry Mount Shawna Symington Submissions from: Division/Section Heads Managers Supervisors 2 Executive Summary Executive Summary Department Structure and Organization The Department of Pathology & Laboratory Medicine (DPLM) comprises the medical and scientific staff for Calgary Lab- oratory Services (CLS). Throughout 2016 it was composed of 6 CLS Divisions and had 84 primary clinical MD appointees and 11 clinical PhD scientists. There were 27 members with University of Calgary GFT and 69 with Clinical Faculty ap- pointments. The Medical/Scientific staff are located at all 5 acute-care hospital sites, at CLS’ central laboratory facility the Diagnostic & Scientific Centre (DSC), and at the University of Calgary Health Sciences Centre, Heritage Medical Research Building, and Health Research Innovation Centre. Accomplishments and Highlights The major clinical accomplishments of each of the 6 Divisions are described individually in the report and are too numer- ous to list here. Academically, 2016 was a record year for publications despite an overall reduction in research FTEs. Our residency training programs and fellowship training programs also continue to thrive. Challenges CLS performs >30 million laboratory tests per year. Every year, we face the challenge of providing increased services with- out proportionate increases in funding. Operationally, our biggest challenges are capital funding and space limitations in acute care sites and the DSC. Workforce Planning Because pathology and laboratory medicine is a service to other specialities, we have no ability to control our own workload, as this is determined by numbers of surgical procedures, orders for laboratory tests, etc. Since laboratory physicians are not fee for service, there is no simple mechanism to fund new positions based upon workload expansion. There is a need to look at laboratory workforce planning from a provincial perspective and ensure that there are adequate clinical FTEs in place to safely handle the increasing workloads. Quality Programs CLS’ comprehensive quality assurance program is based on a Quality Management System model designed to support high quality, cost-effective laboratory services with a strong focus on patient safety. Laboratory-wide performance indicators are reported monthly and there are formal systems in place for serious adverse events, and patient concerns reporting and res- olutions. CLS continues to support provincial laboratory services standardization initiatives including the implementation of the province-wide Anatomic Pathology Quality Assurance Plan. Future Directions and Initiatives The year 2017 will see the recruitment of several new pathologists to fill areas of acute need and replace recent retirements. A number of exciting research initiatives are underway and we will continue to work toward improved integration of labo- ratory services from a provincial perspective. Christopher Naugler, MD Head, Department of Pathology & Laboratory Medicine University of Calgary Cumming School of Medicine/Alberta Health Services – Calgary Zone 3 4 Governance It should be noted that Clinical Sections & Section Chiefs are Divisions and Division Heads in the U of C organizational structure. AHS CALGARY ZONE DEPARTMENT OF PATHOLOGY & LABORATORY MEDICINE CLS Board Interim CLS AHS Calgary Zone Clinical Dept. Head AHS President & CEO Chief Operating Ocer CLS Medical Director, Dr. Christopher Naugler Dr. Verna Yiu Tammy Hofer* CLS Executive VP, Technical Operations VP, Med Operations AHS Calgary Zone Joint AHS Vice President & Medical Director & AHS Medical Scientic Director, Dale Gray Dr. Leland Baskin* Clinical/Academic Dept. Head Medical Direcdtor, Central & Southern Alberta Laboratory Services VP, Corporate Services Dr. Christopher Naugler Dr. Sid Viner Dr. Carolyn O’Hara Wendy Jossa Zone Medical Executive Committe AHS Calgary Zone AHS Calgary Zone Medical CLS Medical Advisory Committee Clinical Department Head Deputy Clinical Department Head Dr. Christopher Naugler Dr. Leland Baskin AP/Cytopathology General Pathology Clinical Biochemistry Hematopathology Transfusion Medicine Microbiology Provincial Laboratory for AHS Zone Clinical AHS Zone Clinical AHS Zone Clinical AHS Zone Clinical AHS Zone Clinical AHS Zone Clinical Public Health Sectlon Chief Section Chief Section Chief Section Chief Section Chief Section Chief Associate Medical Director Dr. Ranjit Waghray Dr. Ethan Flynn Dr. Hossein Sadrzadeh Dr. Meer-Taher Shabani-Rad Dr. Leland Baskin Dr. Deirdre Church Dr. Marie Louie Specialty Groups: Technical Areas: Technical Areas: Technical Area: Technical Area: Technical Areas: − Autopsy − Operational Services − Biochemistry − RRL Hematology − RRL Transfusion − Bacteriology − Breast Pathology − Community Services − Analytical Medicine − Mycology − Cytopathology − POCT Toxicology Specialty Lab: − Parasitology − Dermatopathology − RGH RRL − Immunochemistry − Flow Cytometry Specialty Lab: − Molecular − Gastrointestinal Pathology − Health Centre Testing − Coagulation Lab − Cellular Therapy Microbiology − Genitourinary Labs − Hematology Lab − Gynepathology − ACH RRL − Tissue Typing − Head/Neck and Endocrine − PLC RRL − Molecular Pathology − Mobile Hematology − Neuropathology − Client Interface Team − Red Cell Genotyping − Paediatric Pathology − LIC − Pulmonary Pathology − Patient Appointment Specialty Group: − Renal Pathology-EM Lab Line − South Alberta − Records Management Lymphoma/Leukemia Specialty Labs: Group (SALLG) − Immunohistochemistry Specialty Lab: − Molecular Pathology − Lab Informatics − Cancer Cytogenetics Site Leaders: ACH, DSC, FMC, PLC, RGH, * Denotes Medical/Administrative Dyads SHC March 6, 2016 CLS Governance and Reporting Structure CLS Board Intermim Board Chair Mauro Chies Department Head, Pathology & Laboratory Medicine Cumming School of Medicine; Calgary Laboratory Services ZCDH, Pathology & Laboratory, AHS; Medicial Director, CLS Interim Chief Operating Ocer CLS Medical Advisory Committee AHS Calgary Zone Medical Dr. Christopher Naugler Tammy Hofer Executive Committee Co-Chairs: Dr. Leland Baskin, Dr. Christopher Naugler Biology Safety Ocer (Acting) CLS Executive Dr. Deirdre Church VP, Medical Operations; Deputy Medical Director VP, Technical Operations VP, Corporate Services Dr. Leland Baskin Dale Gray Wendy Jossa Research Functional Center Manager Medical Dyad Dr. Doug Demetrick Quality & Process Sandy Broen-Dupuis Dr. Leland Baskin Excellence Clinical Section Clinical Section Chief Technical Areas, Subspecialty Groups, Specialty Labs Manager General Dr. Ethan Flynn Operational Services Chris Lemaire Pathology Community Services Brenda Strange RGH RRL, PLC RRL, ACH RRL, SHC RRL Denise Connors HCTL, Clinical Education Anita Bamford Functional Center Manager Medical Dyad Specialty Group: Labinformatics Chris Lemaire, Deb Ellas, Anita Bamford Human Resources and Legal Sumana Dr. Chris Naugler Aairs Dasgupta Client Interface Team, LIC, Patient Appointment Line, Records Deb Ellas